StockWatch
·
Pharmaceuticals
AGM/EGM31 Jul 2026, 06:30 pm

NGL Fine-Chem Submits Annual Report, FY26 Revenue ₹501 Cr

AI Summary

NGL Fine-Chem Limited has submitted its Annual Report for the Financial Year 2025-26, along with the notice for its 45th Annual General Meeting (AGM) scheduled for August 25, 2026. The report highlights a significant recovery in FY26, with revenue from operations increasing by 36% to ₹500.95 crores. EBITDA more than doubled to ₹72.69 crores, and profit after tax grew by 128% to ₹48.13 crores. This growth was driven by increased volumes, improved capacity utilization, and disciplined cost management. The company is focusing on expanding into regulated markets and has advanced its CEP, ASMF, and VMF pipelines. Phase I of the greenfield expansion at Tarapur is operational, with Phase II expected to support commercial production from the second half of FY27.

Key Highlights

  • FY26 Revenue ₹501 Cr, up 36% YoY.
  • EBITDA more than doubled to ₹73 Cr.
  • Profit After Tax surged 128% to ₹48 Cr.
  • Greenfield expansion at Tarapur progressing.
  • Focus on regulated markets and global animal health customers.